The future for women leaders in the NHS
Emma Clayton, Managing Director, Grey Bear Consultancy, tells all about Women in Healthcare and how the future is shaping up for women leaders in...
New figures on cancer survival in the UK
Cancer survival in the UK has improved since 1995, but still lags behind other high-income countries, according to new analysis by the International Cancer...
Dependence on prescription medicines uncovered in Public Health England review
A Public Health England review of prescribed medicines has linked dependence on prescription medicines to deprivation. Public Health England has published the first-ever evidence review...
Is in-depth knowledge of the NHS essential to your career?
Oli Hudson, Content Director and John Chater, Solutions Director in Education and Training, at Wilmington Healthcare explain how an in-depth knowledge of the fast-changing...
No deal Brexit and the NHS: A health service on the brink
The BMA has published a new report on the dangers of a no deal Brexit and the NHS. The BMA has repeatedly warned that...
New research into link between HRT and breast cancer
New analyses of the worldwide epidemiological evidence demonstrate link between HRT and breast cancer incidence, and find that some risk persists for many years. An...
Cognitant and UCB deliver immersive VR programme at Addenbrooke’s Hospital
Cognitant Group and UCB have introduced a new programme that provides health information in the form of visual and immersive experiences.This new technology will...
First medically approved back pain app launches in EU and UK
The first medically approved back pain app launches in the EU and UK with the aim to end the nationwide epidemic of back pain...
NICE publishes updated guideline on diagnosis and treatment of hypertension
NICE has issued its final updated guideline on the diagnosis and treatment of hypertension. The final guideline, published by the National Institute for Health and...
Breaking the taboo around HRT
Hormone replacement therapy (HRT) has been battling perceptions of its safety reputation for over 15 years. But for people going through menopause, it can...
Latest articles
Mind the Generation Gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pf Power List 2019: Who is shaping the pharma & healthcare sector?
The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...